RCUS icon

Arcus Biosciences

184 hedge funds and large institutions have $1.36B invested in Arcus Biosciences in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 81 increasing their positions, 54 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

3% more capital invested

Capital invested by funds: $1.33B → $1.36B (+$35.9M)

0.4% less ownership

Funds ownership: 73.13%72.73% (-0.4%)

11% less call options, than puts

Call options by funds: $4.87M | Put options by funds: $5.46M

Holders
184
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.87M
Puts
$5.46M
Net Calls
Net Calls Change

Top Buyers

1 +$21.1M
2 +$17.4M
3 +$9.98M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$9.4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.55M

Top Sellers

1 -$32.5M
2 -$11.1M
3 -$10.3M
4
State Street
State Street
Massachusetts
-$7.69M
5
Morgan Stanley
Morgan Stanley
New York
-$6.03M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$692K
102
$654K
103
$649K
104
$649K
105
$626K
106
$613K
107
$599K
108
$564K
109
$556K
110
$543K
111
$500K
112
$466K
113
$462K
114
$452K
115
$421K
116
$411K
117
$404K
118
$394K
119
$370K
120
$345K
121
$329K
122
$306K
123
$299K
124
$270K
125
$263K